Dr Balwant Singh’s Hospital Laboratory will be extending its testing capabilities to include histopathology tests, special stains, and Immunohistochemistry tests.
This announcement was made by the hospital in a release yesterday. It added that this “significant” upgrade to its laboratory services has been officially accredited by both the Guyana National Bureau of Standards (GNBS) and the American Association for Laboratory Accreditation (A2LA).
The release explained that histopathology, special stains, and immunohistochemistry tests play a crucial role in diagnosing various diseases and conditions.
These tests, it added, will enable the hospital’s medical professionals to provide more accurate and comprehensive patient care. As such, with this expansion of services, “Dr Balwant Singh’s Hospital Laboratory reaffirms its commitment to delivering the highest quality diagnostic solutions to our valued patients and healthcare partners.”
The GNBS has granted accreditation to the hospital’s laboratory’s extended scope of testing under the GYS 170: 2021 standard. This recognition underscores the facility’s compliance with the national guidelines and its dedication to maintaining the highest industry standards.
Furthermore, the laboratory has also received accreditation from the American Association for Laboratory Accreditation (A2LA) under the ISO 15189:2012 standard. According to the release, the A2LA accreditation is a testament to the laboratory’s technical competence and proficiency in delivering accurate and reliable diagnostic results. Chief Executive Officer of Dr. Balwant Singh’s Hospital, Dr Madhu Singh noted, “We are delighted to extend our range of services to include Histopathology, special stains, and Immunohistochemistry tests. This expansion represents a significant milestone for Dr. Balwant Singh’s Hospital Laboratory as we continue to pursue excellence in healthcare diagnostics.”
